{"protocolSection": {"identificationModule": {"nctId": "NCT03608826", "orgStudyIdInfo": {"id": "ReLINQuish"}, "organization": {"fullName": "Medtronic Cardiac Rhythm and Heart Failure", "class": "INDUSTRY"}, "briefTitle": "Relationship Between LINQ\u2122 Subcutaneous Impedance and Right-sided Hemodynamic Measurements", "officialTitle": "Relationship Between LINQ\u2122 Subcutaneous Impedance and Right-sided Hemodynamic Measurements"}, "statusModule": {"statusVerifiedDate": "2022-12", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2018-07-13", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2021-05-07", "type": "ACTUAL"}, "completionDateStruct": {"date": "2021-05-07", "type": "ACTUAL"}, "studyFirstSubmitDate": "2018-06-14", "studyFirstSubmitQcDate": "2018-07-24", "studyFirstPostDateStruct": {"date": "2018-08-01", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2022-11-02", "resultsFirstSubmitQcDate": "2022-12-02", "resultsFirstPostDateStruct": {"date": "2022-12-23", "type": "ACTUAL"}, "dispFirstSubmitDate": "2022-05-04", "dispFirstSubmitQcDate": "2022-12-02", "dispFirstPostDateStruct": {"date": "2022-12-23", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2022-12-02", "lastUpdatePostDateStruct": {"date": "2022-12-23", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Medtronic Cardiac Rhythm and Heart Failure", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": true, "isUsExport": true}, "descriptionModule": {"briefSummary": "The purpose of the ReLINQuish study is to characterize the relationship between subcutaneous impedance and hemodynamic measurements in patients with heart failure. Additionally, the relationship between changes in subcutaneous impedance and other physiologic parameters during acute decompensated HF events will be characterized."}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "DIAGNOSTIC", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 12, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Single Arm Study", "type": "EXPERIMENTAL", "description": "Invesigational RAMware will be downloaded onto the LINQ device.", "interventionNames": ["Device: Investigational LINQ\u2122 HF RAMware"]}], "interventions": [{"type": "DEVICE", "name": "Investigational LINQ\u2122 HF RAMware", "description": "The Reveal LINQ\u2122 device and the 2090 programmer are market-released, but once the investigational LINQ\u2122 HF RAMware is downloaded into the devices, they are considered investigational.", "armGroupLabels": ["Single Arm Study"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Comparison of Reveal LINQ\u2122 Subcutaneous Impedance (Units of Ohms) With Pulmonary Artery Pressure (Units of mmHg) From a Swan-Ganz Catheter During Right Heart Catheterization Procedures in Patients With Heart Failure.", "description": "The primary objective was to characterize the relationship between changes in Reveal LINQ\u2122 subcutaneous impedance and right heart hemodynamic measurements, resulting from: 1) short-term drug and/or exercise challenges during right heart catheterization procedures or 2) long-term daily trends of physiologic data, in patients with heart failure.", "timeFrame": "18 months"}, {"measure": "Comparison of Reveal LINQ\u2122 Subcutaneous Impedance (Units of Ohms) With Right Atrial Pressure (Units of mmHg) From a Swan-Ganz Catheter During Right Heart Catheterization Procedures in Patients With Heart Failure.", "description": "The primary objective was to characterize the relationship between changes in Reveal LINQ\u2122 subcutaneous impedance and right heart hemodynamic measurements, resulting from: 1) short-term drug and/or exercise challenges during right heart catheterization procedures or 2) long-term daily trends of physiologic data, in patients with heart failure.", "timeFrame": "18 months"}], "secondaryOutcomes": [{"measure": "Characterization of the Changes in Reveal LINQ\u2122 Subcutaneous Impedance (Units of Ohms) Prior to Any Acute Decompensated Heart Failure Events.", "description": "The primary objective was to characterize the relationship between changes in Reveal LINQ\u2122 subcutaneous impedance and right heart hemodynamic measurements, resulting from: 1) short-term drug and/or exercise challenges during right heart catheterization procedures or 2) long-term daily trends of physiologic data, in patients with heart failure.", "timeFrame": "18 months"}, {"measure": "Characterization of the Changes in Reveal LINQ\u2122 Activity (Units of Hours Per Day) Prior to Any Acute Decompensated Heart Failure Events.", "description": "A heart failure event is defined as any cardiovascular-related (including hypervolemia) Health Care Utilizations (HCUs) for any one of the following events.\n\n* Admission with primary diagnosis of HF\n* Intravenous HF therapy (e.g. IV diuretics/vasodilators) or ultrafiltration at any one of the following settings:\n\n  * Admission with secondary/tertiary diagnosis of HF\n  * Emergency Department\n  * Ambulance\n  * Observation Unit\n  * Urgent Care", "timeFrame": "18 months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patients meeting at least 1 of 3 criteria will be included in the study:\n\n  * Patients with symptomatic systolic or diastolic heart failure who in the clinician's judgment have a high likelihood of undergoing serial right heart catheterizations to aid in clinical management of their heart failure\n  * Patients with dyspnea on exertion in whom exercise hemodynamics is indicated to diagnose diastolic dysfunction\n  * Patients who have or will be implanted with a pulmonary artery pressure monitor\n* Patient is 18 years of age or older\n* Patient (or patient's legally authorized representative) is willing and able to provide written informed consent\n* Patient is willing and able to comply with the protocol, including follow-up visits and Carelink transmissions.\n\nExclusion Criteria:\n\n* Patient has an existing Medtronic implantable cardiac device\n* Patient has a left ventricular assist device (LVAD)\n* Patient is pregnant (all females of child-bearing potential must have a negative pregnancy test within 1 week of enrollment)\n* Patient is enrolled in another study that could confound the results of this study, without documented pre-approval from a Medtronic study manager", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "Ohio State University", "city": "Columbus", "state": "Ohio", "zip": "43210", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Single Arm Study", "description": "Observational data collection study"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "12"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "2"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "10"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "3"}]}, {"type": "Heart Transplant", "reasons": [{"groupId": "FG000", "numSubjects": "3"}]}, {"type": "Physician Decision", "reasons": [{"groupId": "FG000", "numSubjects": "4"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Single Arm Study", "description": "Single Arm Observational study."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "12"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "57.9", "spread": "9.9"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "4"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "8"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "1"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "11"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "2"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "9"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "1"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "12"}]}]}]}, {"title": "History of Coronary Artery Disease", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "9"}]}]}]}, {"title": "History of Hypertension", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "9"}]}]}]}, {"title": "History of Atrial Fibrillation", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "5"}]}]}]}, {"title": "Left Ventricular Ejection Fraction", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "%", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "36.0", "spread": "21.2"}]}]}]}, {"title": "NYHA class", "description": "NYHA Class I-IV with Class I early stage heart failure, and Class IV end stage heart failure.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Class-II", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}]}]}, {"title": "Class-III", "categories": [{"measurements": [{"groupId": "BG000", "value": "9"}]}]}, {"title": "Missing", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Comparison of Reveal LINQ\u2122 Subcutaneous Impedance (Units of Ohms) With Pulmonary Artery Pressure (Units of mmHg) From a Swan-Ganz Catheter During Right Heart Catheterization Procedures in Patients With Heart Failure.", "description": "The primary objective was to characterize the relationship between changes in Reveal LINQ\u2122 subcutaneous impedance and right heart hemodynamic measurements, resulting from: 1) short-term drug and/or exercise challenges during right heart catheterization procedures or 2) long-term daily trends of physiologic data, in patients with heart failure.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "18 months", "groups": [{"id": "OG000", "title": "Observation", "description": "Observation arm"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Comparison of Reveal LINQ\u2122 Subcutaneous Impedance (Units of Ohms) With Right Atrial Pressure (Units of mmHg) From a Swan-Ganz Catheter During Right Heart Catheterization Procedures in Patients With Heart Failure.", "description": "The primary objective was to characterize the relationship between changes in Reveal LINQ\u2122 subcutaneous impedance and right heart hemodynamic measurements, resulting from: 1) short-term drug and/or exercise challenges during right heart catheterization procedures or 2) long-term daily trends of physiologic data, in patients with heart failure.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "18 months", "groups": [{"id": "OG000", "title": "Observation", "description": "Observation arm"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Characterization of the Changes in Reveal LINQ\u2122 Subcutaneous Impedance (Units of Ohms) Prior to Any Acute Decompensated Heart Failure Events.", "description": "The primary objective was to characterize the relationship between changes in Reveal LINQ\u2122 subcutaneous impedance and right heart hemodynamic measurements, resulting from: 1) short-term drug and/or exercise challenges during right heart catheterization procedures or 2) long-term daily trends of physiologic data, in patients with heart failure.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "18 months", "groups": [{"id": "OG000", "title": "Observation", "description": "Observation arm"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "9"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Characterization of the Changes in Reveal LINQ\u2122 Activity (Units of Hours Per Day) Prior to Any Acute Decompensated Heart Failure Events.", "description": "A heart failure event is defined as any cardiovascular-related (including hypervolemia) Health Care Utilizations (HCUs) for any one of the following events.\n\n* Admission with primary diagnosis of HF\n* Intravenous HF therapy (e.g. IV diuretics/vasodilators) or ultrafiltration at any one of the following settings:\n\n  * Admission with secondary/tertiary diagnosis of HF\n  * Emergency Department\n  * Ambulance\n  * Observation Unit\n  * Urgent Care", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "18 months", "groups": [{"id": "OG000", "title": "Observation", "description": "Observation arm"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "9"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Adverse event data was collected up to 18 months from enrollment.", "eventGroups": [{"id": "EG000", "title": "Single Arm", "description": "Observation Arm", "deathsNumAffected": 3, "deathsNumAtRisk": 12, "seriousNumAffected": 4, "seriousNumAtRisk": 12, "otherNumAffected": 0, "otherNumAtRisk": 12}], "seriousEvents": [{"term": "Hospitalization", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "There was one hospitalization which was deemed a serious adverse event on day 285 after insertion procedure which could not be ruled out as related to device or insertion procedure.", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 12}]}, {"term": "Death", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 12}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "No right heart catheterization was performed during the study, hence the primary outcome could not be summarized. The LINQ device data was not available prior to the acute decompensated heart failure events, hence the secondary outcome could not be summarized."}, "certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Nicole Wood", "organization": "Medtronic", "email": "nicole.wood@medtronic.com", "phone": "8006338766"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2017-11-17", "uploadDate": "2022-11-02T17:26", "filename": "Prot_SAP_000.pdf", "size": 4228368}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "submissionTracking": {"firstMcpInfo": {"postDateStruct": {"date": "2022-11-30", "type": "ACTUAL"}}}}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}